Helios And Matheson Analytics Inc Profit Margin 2010-2018 | HMNY
Current and historical gross margin, operating margin and net profit margin for Helios And Matheson Analytics Inc (HMNY) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Helios And Matheson Analytics Inc net profit margin as of September 30, 2018 is 0%.
| Helios And Matheson Analytics Inc Annual Profit Margins |
|---|
| Helios And Matheson Analytics Inc Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.000B | $0.000B |
| The A Consulting Team (TACT) is a consulting firm organized into three components: Application Development, Database Management, and Networking Systems/Communication. Backed up by this extensive technical organization, TACT's three departments, which consist of Consulting, Software and Technical Training, distribute state-of-the-art technical knowledge and capabilities to meet any business goal. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $20.441B | 12.36 |
| Quest Diagnostics (DGX) | United States | $17.300B | 17.53 |
| DaVita (DVA) | United States | $12.524B | 16.20 |
| Encompass Health (EHC) | United States | $9.893B | 23.32 |
| Chemed (CHE) | United States | $8.232B | 25.30 |
| Elanco Animal Health (ELAN) | United States | $5.982B | 14.24 |
| RadNet (RDNT) | United States | $5.799B | 128.43 |
| Option Care Health (OPCH) | United States | $3.998B | 18.94 |
| Amedisys (AMED) | United States | $2.806B | 19.97 |
| LifeStance Health (LFST) | United States | $2.744B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.267B | 26.60 |
| Astrana Health (ASTH) | United States | $2.117B | 28.95 |
| U.S Physical Therapy (USPH) | United States | $1.411B | 37.09 |
| Pennant (PNTG) | United States | $1.000B | 40.43 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.972B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.228B | 0.00 |
| Daxor (DXR) | United States | $0.039B | 0.00 |
| Psychemedics (PMD) | United States | $0.016B | 0.00 |
| Ontrak (OTRK) | United States | $0.007B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.006B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.001B | 0.00 |